Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
dc.contributor.author | Kariyawasarn, HH | en_US |
dc.contributor.author | James, LK | en_US |
dc.date.accessioned | 2024-01-09T15:27:13Z | |
dc.date.available | 2020-11-24 | en_US |
dc.date.issued | 2020 | en_US |
dc.identifier.issn | 1177-8881 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/93674 | |
dc.format.extent | 5483 - 5494 | en_US |
dc.relation.ispartof | DRUG DESIGN DEVELOPMENT AND THERAPY | en_US |
dc.rights | Attribution-NonCommercial 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/us/ | * |
dc.subject | IgE | en_US |
dc.subject | nasal polyps | en_US |
dc.subject | omalizumab | en_US |
dc.subject | rhinosinusitis | en_US |
dc.title | Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy | en_US |
dc.type | Article | |
dc.identifier.doi | 10.2147/DDDT.S226575 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000601315700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 14 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]